About Ark Biotech
Ark Biotech is a company based in Boston (United States) founded in 2021 by Yossi Quint.. Ark Biotech has raised $10.68 million across 2 funding rounds from investors including Primary. Ark Biotech offers products and services including Simulation Software and Bioreactor Model. Ark Biotech operates in a competitive market with competitors including PBS Biotech, Hyalose, Distek, ReelReactor and Choncept, among others.
- Headquarter Boston, United States
- Founders Yossi Quint
-
Sectors
ConsumerHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.68 M (USD)
in 2 rounds
-
Latest Funding Round
$8.18 M (USD), Series A
May 10, 2024
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ark Biotech
Ark Biotech offers a comprehensive portfolio of products and services, including Simulation Software and Bioreactor Model. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Software for virtual bioreactor simulations to optimize bioprocess parameters.
Tool for predicting cell culture trends and scaling processes efficiently.
Unlock access to complete
Software Development Team
1 people
Leadership Team
1 people
Senior Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Ark Biotech
Ark Biotech has successfully raised a total of $10.68M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $8.18 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $8.2M
-
First Round
First Round
(23 Dec 2021)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Series A - Ark Biotech | Valuation |
investors |
|
| Dec, 2021 | Amount | Seed - Ark Biotech | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Ark Biotech
Ark Biotech has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Primary. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in seed-stage companies are managed by Primary Venture Partner.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Ark Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Ark Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ark Biotech Comparisons
Competitors of Ark Biotech
Ark Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PBS Biotech, Hyalose, Distek, ReelReactor and Choncept, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies
|
|
| domain | founded_year | HQ Location |
Recombinant hyaluronic acid is manufactured in varying molecular sizes.
|
|
| domain | founded_year | HQ Location |
Produces dissolution apparatus and bioprocessing equipment for pharmaceutical testing.
|
|
| domain | founded_year | HQ Location |
Continuous reactor developed for biological products and therapies production.
|
|
| domain | founded_year | HQ Location |
Develops innovative chondroitin technologies through recombinant bacteria fermentation.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ark Biotech
Frequently Asked Questions about Ark Biotech
When was Ark Biotech founded?
Ark Biotech was founded in 2021.
Where is Ark Biotech located?
Ark Biotech is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Who is the current CEO of Ark Biotech?
Yossi Quint is the current CEO of Ark Biotech. They have also founded this company.
Is Ark Biotech a funded company?
Ark Biotech is a funded company, having raised a total of $10.68M across 2 funding rounds to date. The company's 1st funding round was a Seed of $2.5M, raised on Dec 23, 2021.
What does Ark Biotech do?
Ark Biotech was founded in 2021 and is based in Boston, United States. Operations focus on the biotechnology sector, where bioreactors and associated operating systems are manufactured for the industrial-scale production of cultivated meat. Development efforts target scalable solutions to support this emerging protein technology, with activities centered on hardware and software integration for efficient cultivation processes.
Who are the top competitors of Ark Biotech?
Ark Biotech's top competitors include PBS Biotech, Hyalose and ReelReactor.
What products or services does Ark Biotech offer?
Ark Biotech offers Simulation Software and Bioreactor Model.
Who are Ark Biotech's investors?
Ark Biotech has 1 investor. Key investors include Primary.